← Browse by Condition
Medical Condition
interstitial lung disease ild
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT07482917
Recruiting
Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial
Enrollment
92 pts
Location
Spain
Sponsor
Hospital de Granollers
NCT06992661 Phase 1
Recruiting
A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With Interstitial Lung Disease
Enrollment
84 pts
Location
China
Sponsor
Ruijin Hospital